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Lipase catalysed kinetic resolutions of 3-aryl alkanoic acids. 
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Abstract 
 
Hydrolase catalysed kinetic resolutions leading to a series of 3-aryl alkanoic acids (≥94% ee) 
is described. Hydrolysis of the ethyl esters with a series of hydrolases was undertaken to 
identify biocatalysts that yield the corresponding acids with excellent enantiopurity in each 
case. Steric and electronic effects on the efficiency and enantioselectivity of the biocatalytic 
transformation was also explored.  
 
Introduction 
 
Lipases (triacylglycerol ester hydrolases, EC 3.1.1.3) are ubiquitous enzymes belonging to 
the family of serine hydrolases and are unequivocally, the most utilized enzymes in 
biocatalysis, providing one of the most advantageous and versatile biocatalytic methods in 
asymmetric synthesis.
1-11
 Hydrolases are excellent biocatalysts, combining wide substrate 
specificity with high regio- and enantioselectivity enabling the resolution of organic 
substrates with superb efficiency and selectivity.
12-14
 Furthermore, hydrolases do not require 
the use of labile co-factors, can be recycled, can be used in both free or immobilised form and 
are effective under mild, environmentally benign conditions and are biodegradable. These 
attributes make these catalysts especially attractive for the pharmaceutical and agrochemical 
areas, where the interest for enantiomerically pure and specifically functionalized compounds 
is continuously growing.
2;4-11 
 
Hydrolase catalysed kinetic bioresolution is widely used to provide highly enantioenriched 
chiral carboxylic acids, which are valuable synthetic intermediates for the preparation of a 
variety of compounds of biological interest. There have been many reports on the successful 
resolution of 2-aryl or 2-aryloxy-propionic acids; the former are non-steroidal anti-
inflammatory drugs and the latter an important class of herbicides.
15-20
 Successful hydrolase 
catalysed resolution of alkanoic acids, with remotely located methyl-branching has been 
reported,
21;22
 however the literature has revealed limited success on the hydrolase mediated 
kinetic resolution of 3-aryl alkanoic acids. Enantiomerically pure 3-aryl alkanoic acids are 
used as chiral synthons in the asymmetric synthesis of antibacterial agents such as (-)-
malyngolide, a naturally occurring δ-lactone of algae origin,23 curcumene and curcuphenol, 
biological important bisabolene sesquiterpenes
24
 and in the synthesis of amino acids β-methyl 
phenylalanaine
25
 and β-methyl tyrosine.26 Within our own group, 3-aryl alkanoic acids are 
utilised in the synthesis of diazoketone derivatives, which in turn have been employed in 
Buchner cyclization reactions demonstrating excellent diastereoselectivity.
27;28
 This key 
transformation is currently under investigation in the efficient asymmetric synthesis of the 
bicyclo[5.3.0]decane skeleton, characteristic of daucane sesquiterpenoids. 
Hydrolase catalysed non-aqueous enantioselective esterification of acids (±)-1a, (±)-1b, (±)-
1c and (±)-1d, (Figure 1) has previously been reported, however substrate acids (±)-1a and 
(±)-1b were esterified with a modest to slow rate resulting in very low E values (E<2) and no 
ester was observed under any conditions for acids (±)-1c and (±)-1d.
29
 Traditional aqueous 
Burkholderia cepacia catalysed ester hydrolysis has been described for the resolution of 3-
phenylbutanoic acid (±)-1a (E>50), however this work has not been expanded to include acid 
substrates (±)-1b, (±)-1c, and (±)-1d, encompassing more sterically hindered substituents at 
the stereogenic centre.
30
  
 
Figure 1. 
 
In this study, we wished to explore a wide range of hydrolases to establish if it is possible to 
generate the carboxylic acid (±)-1a-i in enantiopure form through kinetic bioresolution. Acids 
(±)-1a-d, were selected for investigation to determine the impact of steric effects at C3 on the 
efficiency of the kinetic resolution, while substrates (±)-1e-i were designed to explore both 
steric and electronic effects of substituents on the aromatic ring on the biotransformations. In 
contrast to the limited reported success in enantioselective esterification, this study focussed 
on enantioslective hydrolysis and indeed it was found that through appropriate choice of 
biocatalyst and reaction conditions, each of the carboxylic acids could be obtained in highly 
enantioenriched form.   
 
Results and Discussion 
 
Synthesis of ethyl 3-aryl alkanoates. 
 
Racemic ester (±)-3a was obtained via a simple Fischer esterification reaction from 
commercial 3-phenylbutanoic acid (±)-1a (Scheme 1). The 3-aryl alkanoic esters (±)-3b-h 
were synthesized in a three step synthesis. Acids (±)-1b-d were synthesised by conjugate 
addition of an alkyl Grignard to cinnamic acid, while acids (±)-1e-h were similarly prepared 
by conjugate addition of the appropriate aryl Grignard to crotonic acid.
31
 While direct 
esterification of the crude carboxylic acid was attempted, it was found that it was simpler to 
obtain the ethyl esters in analytically pure form by first transforming the carboxylic acid (±)-
1b-h isolated from Grignard additions directly to the analogous acid chloride which was 
readily purified by vacuum distillation. Treatment of the pure acid chloride with ethanol in 
the presence of triethylamine led to analytically pure ester (Scheme 1). An alternative route 
via a Wadsworth-Emmons reaction was employed in synthesising ethyl 3-(4-
fluorophenyl)butanoate (±)-3i (Scheme 2)
32
. Acids 1a-e and 1h have been previously 
reported in the literature in enantioenriched form and therefore the assignment of absolute 
stereochemistry for each of these compounds was made by comparison of specific rotation 
data. Acids 1f-g and 1i have not been previously reported in enantiopure form and the 
absolute stereochemistry was determined in each case through crystallography studies. 
 
Scheme 1. Synthesis of ethyl 3-aryl alkanoate (±)-3a-h. Reagents: (i) R
2
MgX, Et2O, (±)-1b-
d; (ii) Et2O, (±)-1e-h; (iii) SOCl2; (iv) Et3N, EtOH, CH2Cl2; (v) EtOH, cat. H2SO4, (±)-1a. 
 
 
Scheme 2. Synthesis of ethyl 3-(4-fluorophenyl)butanoate (±)-3i and ethyl 3-(4-
fluorophenyl)butanoic acid (±)-1i. Reagents: (i) (C2H5O)2P(O)CH2CO2Et, NaH, THF; (ii) H2, 
Pd/C, EtOH; (iii) NaOH.
32
 
 
With racemic samples of both the esters and acids in hand, chiral HPLC conditions were 
developed for each ester hydrolysis in which both enantiomers of the ester and acid could be 
seen on a single trace (Figure 2).  With a single injection, ready monitoring of both the 
efficiency and stereoselectivity of each of the hydrolase mediated transformations could be 
performed. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 2: An overlay of HPLC traces of (a) A racemic mixture of ethyl 3-(3-
methylphenyl)butanoic acid (±)-1f and ethyl 3-(3-methylphenyl)butanoate (±)-3f. (b) 
Enantiopure ethyl 3-(3-methylphenyl)butanoate (R)-3f and (c) Enantiopure 3-(3-
methylphenyl)butanoic acid (S)-1f. See Table 7 for chiral HPLC conditions. 
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Hydrolase catalysed kinetic resolution of (±)-3-phenylbutanoic acid (±)-1a 
 
In total, 21 lipases and 1 esterase were screened in resolving racemic 3-phenylbutanoic acid 
(±)-1a. All of the hydrolases investigated resulted in hydrolysis of ethyl 3-phenylbutanoate 
(±)-3a to a certain extent and the screening results are summarised in Table 1. Pseudomonas 
cepacia, Alcaligenes spp. and Pseudomonas fluorescens, entry 6, 11 and 15 respectively, 
exhibited excellent enantioselection in the hydrolysis of substrate (±)-3a. Burholderia 
cepacia hydrolysis of the methyl ester of (±)-1a had previously been reported (E>50) 
providing access to the acid (S)-1a with 89% ee.
30
 In this study, Alcaligenes spp. yielded the 
acid (S)-1a with excellent improved enantioselectivity of 97% ee (E>200) by hydrolysis of 
the corresponding ethyl ester (±)-3a. Unreacted (R)-3a was recovered in 98% ee providing 
access to both enantiomeric series in a single resolution. 
 
From Table 1, it is evident that certain hydrolases hydrolysed the (R) enantiomer of substrate 
(±)-3a preferentially, providing access to the complementary enantiomer (R)-1a. Candida 
antarctica lipase B hydrolysis of (±)-3a had previously been reported to yield (R)-1a, 
(E=9),
33
 while in this work, (Table 1, entry 16) it is clear that the (R) ester is selectively 
hydrolysed albeit at very low enantioselectivity. The less common pathway involving 
selective hydrolysis of the (R) ester has been successfully extended in this study to include 
the hydrolases Candida Cyclindracea, and Mucor meihei.
33
   
 
To demonstrate the practical viability of this process, Pseudomonas fluorescens was selected 
as the most appropriate hydrolase for preparative scale use. The conversion and enantiopurity 
of the esters and acids were analysed utilising chiral HPLC and after 64h, 50% conversion 
was achieved with 98% eeacid and 99% eeester corresponding to an E value >200. Enantiopure 
samples of (S)-1a and (R)-3a were isolated by chromatography in 34% and 35% yield 
respectively. Column chromatography proved more effective than acid-base extraction for 
recovery of the ester and acid in this instance. 
 
In practise, while use of Candida antarctica lipase B, Candida Cyclindracea and Mucor 
meihei all lead selectively to (R)-1a, access to the enantiopure (R)-1a is more effectively 
achieved through isolation of enantiopure (R)-3a using Pseudomonas cepacia, Alcaligenes 
spp. and Pseudomonas fluorescens, followed by saponification. 
 
 
 
 
 
 
 
 
 
 
 
 
Table  1. Hydrolase-mediated hydrolysis of (±)-ethyl 3-phenylbutanaoate (±)-3a. 
 
 
Entry Enzyme Temp (°C) ee
a
 (%) Conversion
b
 
 (%) 
E 
value
b
 Ester 3a Acid 1a  
1 Candida cyclindracea 
C1 
30 11 (S) 58 (R) 16 4.2 
2 Candida  cyclindracea 
C2 
Ambient 25 (S) 59 (R) 30 4.9 
3 Rhizopus oryzae 30 - - <10
c
 - 
4 Achromobacter spp. 30 11 (R) 90 (S) 11 21 
5 Alcaligenes spp. 1 30 27 (R) 95 (S) 22 50 
6 Pseudomonas  cepacia 
P1 
30 99 (R) 94 (S) 51 170 
7 Pseudomonas stutzeri Ambient 14 (R) 61 (S) 19 4.7 
8 Rhizopus spp. Ambient - - <10
c
 - 
9 Rhizopus niveus Ambient - - <10
c
 - 
10 Aspergillus niger Ambient - - <10
c
 - 
11 Alcaligenes spp. 2 Ambient 98 (R) 97 (S) 50 >200 
12 Pseudomonas  cepacia 
P2 
Ambient 96 (R) 75 (S) 56 26 
13 Mucor javanicus Ambient - - <10
c
 - 
14 Penicillium 
camembertii 
Ambient - - <10
c
 - 
15 Pseudomonas 
fluorescens 
30 99 (R) 94 (S) 51 170 
16 Candida antarctica 
lipase B 
Ambient 13 (S) 0 (R) 51 1.4 
17 Mucor meihei Ambient 3 (S) 24 (R) 11 1.7 
18 Candida antarctica 
lipase A 
Ambient 10 (R) 68 (S) 13 5.8 
19 Candida antarctica 
lipase B (immob) 
Ambient 70 (S) 5 (R) 93 1.8 
20 Porcine pancrease 
Type II 
Ambient 15 (R) 93 (S) 14 31 
21 Porcine pancrease 
Grade II 
30 35 (R) 95 (S) 27 54 
22 Pig liver esterase Ambient - - <10
c
 - 
 
a
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 95:5, flow rate 0.5 mL/min, 0 °C, λ=209.8 nm]. 
b
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of substrate 
ester 3a (ees) and product acid 1a (eep).
34
 
c
Estimated by chiral HPLC. 
 
Hydrolase catalysed kinetic resolution of (±)-3-phenylpentanoic acid (±)-1b 
 
The enzymatic hydrolysis of (±)-ethyl 3-phenylpentanoate (±)-3b proved to be significantly 
less facile than with (±)-3a. Of the 16 hydrolases screened, many displayed no catalytic 
activity for hydrolysis of the substrate ethyl 3-phenylpentanoate (±)-3b. Thus replacement of 
the methyl with the slightly larger ethyl moiety at the stereogenic centre C3 resulted in a very 
significant reduction of enzymatic activity. Just 6 of the hydrolases resulted in conversion as 
summarised in Table 2.  
 
Significantly the biocatalysts which had yielded the most effective kinetic bioresolution with 
(±)-3a were ineffective for enzymatic hydrolysis of (±)-3b. For the 6 biocatalysts which 
resulted in ester hydrolysis the enantioselectivities were modest at best (Table 2). 
Interestingly with entries 2, 3 and 5 the poor enantioselectivity is associated with lack of 
discrimination of the enantiomers by the biocatalyst with conversions ≥78% in each case, 
while the same biocatalysts with (±)-3a gave very limited reaction. The immobilised Candida 
antarctica lipase B provided the best results in this instance (E=25), this is in direct contrast 
to the limited reaction of (±)-3a with Candida antarctica lipase B (immob). 
 
The direction of enantioselection in the hydrolysis of (±)-3b was consistent with that 
observed in the reactions of (±)-3a with Candida antarctica lipase B, Candida antarctica 
lipase B (immob) and Pig liver esterase providing the (R) acid selectively. Based on the 
initial promising result with Candida antarctica lipase B (immob) variation of the reaction 
conditions for the hydrolysis was undertaken to determine if the outcome could be optimised.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Hydrolase-mediated hydrolysis of (±)-ethyl 3-phenylpentanoate (±)-3b. 
 
Temperature control in hydrolase-catalyzed resolutions has been explored due to its 
simplicity and reliability for enhancement of enantioselectivity, albeit at the expense of 
longer reaction times.
7;35;36
 Thus Candida antarctica lipase B (immob) resolution of (±)-3b, 
was performed at 4 C, (Table 2, entry 7) resulting in a decrease in the extent of conversion 
even with an extended incubation period. No significant increase in enantioselection was 
observed, therefore this approach was not pursued further.  
 
The utilisation of organic co-solvents has been well established to increase the 
enantioselectivity of hydrolase catalysed resolution of an extensive range of 
compounds.
10;37;38
 Screening reactions were therefore performed to assess the effect of a 
series of co-solvents (at 17% v/v) on Candida antarctica lipase B (immob) resolution of (±)-
3b (Table 3). The majority of co-solvents investigated resulted in a decrease in the rate of 
hydrolysis, but notably, with the exception of TBME, resulted in an equivalent or an 
improved enantiopurity of (R)-1b. The utilisation of acetone as an additive, (Table 3, entry 3) 
resulted in recovery of (R)-1b with 94% ee and E=41 while with dioxane (Table 3, entry 5) 
E=51. Thus hydrolase catalysed resolution can be effective as a route to enantioenriched (R)-
1b provided the biocatalyst and reaction conditions are carefully chosen. The only prior 
 
Entry Enzyme
a
 Time Temp 
(°C) 
ee
b
 (%) Conversion
c
 
(%) 
E 
Value
c
 
Ester 
3b 
Acid  
1b 
  
1 Candida 
cyclindracea C2 
120 h Ambient - - <10
d
 - 
2 Candida antarctica 
lipase B 
65 h Ambient 80 (S) 23 (R) 78 3.4 
3 Mucor meihei 67 h Ambient -
e
 -
e
 100 -
e
 
4 Candida antarctica 
lipase A 
67 h Ambient 5 (R) 44
 
(S) 10 2.7 
5 Pig liver esterase 65 h Ambient 87 (S) 15 (R) 85 3.1 
6 Candida antarctica 
lipase B (immob) 
65 h Ambient 85 (S) 81 (R) 51 25 
7 72 h 4 62 (S) 86 (R) 42 24 
 
a
The following hydrolases gave no conversion Pseudomonas cepacia P2, Pseudomonas cepacia 
P1, Alcaligenes spp. 2, Pseudomonas fluorescens, Porcine Pancrease Type II, Pseudomonas 
stutzeri, Rhizopus niveus, Candida cyclindracea C1, Aspergillus niger and Mucor javanicus.    
b
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 99:1, flow rate 0.5 mL/min, 0 °C, λ=209.8 nm].  
c
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of substrate 
ester 3b (ees) and product acid 1b (eep).
34
 
d
Estimated by chiral HPLC. 
e
Reaction went to 100% completion, no enantioselectivity observed. 
 
report of hydrolase catalysed esterification of 1b describes very low activity and 
enantioselectivity (E<2).
29
 Furthermore, the acid (S)-1b has been resolved using amidase 
biocatalysis and again enantiopurity was lower (88% ee).
39
   
 
Table 3. Investigation of co-solvent effect on Candida antarctica lipase B (immob) 
hydrolysis of (±)-ethyl 3-phenylpentanoate (±)-3b 
 
Hydrolase catalysed kinetic resolution of (±)-4-methyl-3-phenylpentanoic acid (±)-1c 
 
Given the decrease in biocatalytic activity on increasing the C3 substituent from methyl to 
ethyl it was anticipated that enzymatic hydrolysis to form (S)-1c and (S)-1d with the more 
sterically demanding i-propyl and t-butyl substituents would prove extremely challenging. Of 
the 19 hydrolases screened many displayed no hydrolytic activity towards (±)-3c, and 
hydrolysis failed to occur even at elevated temperature and extended reaction periods. 
Significantly, the hydrolases that were identified to hydrolyse (±)-3b were found to hydrolyse 
(±)-3c as depicted in Table 4 confirming that these biocatalysts can accommodate increased 
steric demand in the C3 region of the enzyme pocket. 
 
Interestingly the extent of reaction in entries 1, 2 and 4, Table 4, is decreased somewhat 
relatively to those seen with (±)-3b in Table 2, resulting in improved enantiopurities of the 
recovered acid (S)-1c. Thus discrimination between the phenyl and i-propyl groups in the 
active site of the enzymes is improved somewhat relative to that seen in (±)-3b where 
discrimination between the ethyl and phenyl substituents is quite poor. While the R, S labels 
in the acid (S)-1c are switched relative to acids (R)-1a and (R)-1b the sense of 
enantioselection is identical in hydrolysis of the ethyl and i-propyl esters (±)-3b and (±)-3c 
with the S enantiomer isolated using enzymes Candida antarctica lipase B, Mucor meihei and 
Candida antarctica lipase B (immob). In this instance (S)-1c was obtained in 99% ee using 
Candida antartica lipase B; hence no further optimisation was required. 
Entry Co-solvent Time Temp  
(°C) 
ee
b
 (%) Conversion
c
  
(%) 
E 
value
c
 
Ester 
(S)-3b 
Acid 
(R)-1b 
  
1 DMSO 64 h Ambient 93 81 53 31 
2 Acetonitrile
a
 64 h Ambient 28 93 23 36 
3 Acetone
a
 64 h Ambient 25 94 21 41 
4 THF 64 h Ambient 6 88 6 16 
5 Dioxane 64 h Ambient 72 92
d
 44 51 
6 TBME
a
 64 h Ambient 24 57 30 4.6 
 
a
HPLC grade 
b
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 99:1, flow rate 0.5 mL/min, 0 °C, λ=209.8 nm].  
c
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of substrate 
ester 3b (ees) and product acid 1b (eep).
34
 
d
On one occasion the enantiomeric excess isolated from dioxane of (R)-1b was 97% ee. 
 
Once again careful control of reaction conditions and selection of biocatalyst leads to 
efficient bioresolution of (S)-1c, in direct contrast to the literature report which states it was 
not possible to resolve this acid using hydrolase catalysis.
29
 
 
A solvent screen involving dioxane, acetone and TBME was conducted for Candida 
antarctica lipase A and Candida antarctica lipase B resolution of (±)-3c to investigate the 
effect on enantiomeric excess, but resulted in a significant reduction in activity and therefore 
was no longer pursued. 
 
Table 4. Hydrolase-mediated hydrolysis of (±)-ethyl 4-methyl-3-phenylpentanoate (±)-3c. 
 
Hydrolase catalysed kinetic resolution of (±)-4,4-dimethyl-3-phenylpentanoic acid (±)-1d 
 
Hydrolase catalaysed resolution of ethyl 4,4-dimethyl-3-phenylpentanoate (±)-3d was 
achieved using the same biocatalysts which catalysed reaction of (±)-3b and (±)-3c albeit at 
much lower extent of conversion presumably due to the increased steric demand of the C3 
substituent. However, the overall trends are very similar for (±)-3b, (±)-3c and (±)-3d with 
the optimum results achieved with the immobilised or free Candida antarctica Lipase B, 
(Figure 3). While the extent of reaction at room temperature was extremely limited, increase 
of temperature improved the conversion somewhat, see for example entries 2 and 6, Table 5. 
 
Entry Enzyme
a
 ee
b
 (%) Conversion
c
 
(%) 
E 
value
c
 Ester 3c Acid 1c 
1 Candida antarctica lipase B 12 (R) 99 (S) 11 >200 
2 Mucor meihei 61 (R) 23 (S) 73 2.7 
3 Candida antarctica lipase A 10 (S) 64 (R) 14 5 
4 Candida antarctica lipase B 
(immob) 
33 (R) 97 (S) 25 90 
5 Pig liver esterase -
d
 -
d
 100 -
d
 
 
a
The following hydrolases gave no conversion Pseudomonas cepacia P2, Pseudomonas 
cepacia P1, Alcaligenes spp. 1, Penicillium camembertii,  Pseudomonas fluorescens, Porcine 
Pancrease Type II, Candida cyclindracea C2, Rhizopus spp., Pseudomonas stutzeri, 
Rhizopus niveus, Candida cyclindracea C1, Aspergillus niger,  Alcaligenes spp. 2 and Mucor 
javanicus
 
b
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 98:2, flow rate 0.5 mL/min, 0 °C, λ=209.8 nm].  
c
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3c (ees) and  product acid 1c (eep).
34
 
d
Reaction went to 100% completion, no enantioselectivity observed. 
 
The direction of enantioselectivities is consistent with earlier observations for Candida 
antarctica lipase B (immob) and Candida antarctica lipase A. Interestingly the sense of 
enantioselection in the Pig liver esterase hydrolase, resulting in selective hydrolysis of the 
(R) enantiomer, is opposite to that seen in the hydrolysis of the corresponding ethyl derivative 
(±)-3b. Thus, in the ethyl derivative (±)-3b Candida antarctica lipase A provided the (S) 
enantiomer of the acid selectively while Pig liver esterase provides the (R) enantiomer 
selectively, whereas the t-butyl derivative Pig liver esterase displays the same direction of 
enantioselection as Candida antarctica lipase A. 
 
With both the free and immobilised Candida antarctica lipase B, while the extent of the 
hydrolyse is limited the enantioselectivity is excellent, with the acid (S)-1d isolated in 
enantiopure form. Increasing the temperature improved the conversion somewhat, thereby 
resulting in an increased enantiopurity of the unreacted ester (R)-3d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Hydrolase-mediated hydrolysis of (±)-ethyl 4,4-dimethyl-3-phenylpentanoate (±)-3d 
at variable temperature.  
 
It is evident that once the alkyl group at the C3 stereogenic centre increases in size greater 
than a methyl substituent, a dramatic decrease in the efficiency of the hydrolysis and thereby 
the kinetic bioresolution with regards to the enantiopurity of the ester is observed. Despite the 
steric hindrance within the active site, 3-aryl alkanoic carboxylic acids 1a-d can be obtained 
through optimisation of reaction conditions with excellent enantioselectivity. The acid (S)-1a 
was obtained in 98% ee, through Pseudomonas fluorescens catalysed hydrolysis of (±)-3a, 
 
Entry Enzyme
a
  Temperature 
°C 
ee
e 
(%) Conversion
f
 
(%) 
E value
f
 
Ester 3d Acid 1d  
1 Candida 
antarctica 
lipase B 
Ambient
b
 2 (R) ≥99h (S) 2 >200 
2 35 °C – 40 °Cc 23 (R) ≥99h (S) 19 >200 
3 Candida 
antarctica 
lipase A 
Ambient
b
 3
 
(S) 73
 
(R) 4 6.6 
4 35 °C – 40 °Cd 7 (S) 81 (R) 8 10 
5 Candida 
antarctica 
lipase B 
(immob) 
Ambient
b
 1 (R) ≥99h (S) 1 >200 
6 35 °C – 40 °Cc 
 
30 (R) 98 (S) 23 
 
132 
7 Pig liver 
esterase 
Ambient
b
 32 (S) 34 (R) 48 2.7 
8 35 °C – 40 °Cc 
 
-
g
 -
g
 100 -
g
 
 
a
The following hydrolases gave no conversion Pseudomonas cepacia P1, Rhizopus niveus, 
Pseudomonas fluorescens, Candida cyclindracea C1,  Pseudomonas cepacia P2 and Porcine 
Pancrease Type II.
 
b
Time for ester hydrolysis was 66 h. 
c
Time for ester hydrolysis was 64.5 h at 35 °C temperature increased to 40 °C for the final 24 h. 
d
Time for ester hydrolysis was 72 h at 35 °C temperature increased to 40 °C for the final 24 h. 
e
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 96:4, flow rate 0.25 mL/min, 20 °C, λ=209.8 nm].  
f
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of substrate 
ester 3d (ees) and  product acid 1d (eep).
34
 
g
Reaction went to 100% completion, no enantioselectivity observed. 
hWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
while acids (R)-1b, (S)-1c and (S)-1d were obtained in ≥94% ee via immobilised or free 
Candida antarctica lipase B catalysed kinetic bioresolution (Figure 3).  
 
Figure 3. Graph of enantiomeric ratio (E) versus hydrolase – Kinetic bioresolutions for 1a-d 
performed under standard aqueous conditions.  
 
Significantly, Candida antarctica lipase A provides a viable route to the complementary 
enantiomers (S)-1b and (R)-1c-d overcoming the limitation of the modest enantiomeric 
excess of the esters achieved in the resolutions using the free and immobilised Candida 
antarctica lipase B. In addition, Candida antarctica lipase A has a unique ability to accept 
very bulky, highly sterically hindered substrates and this correlated with the observations of 
this study where the enantiopurity of the acid obtained via Candida antartica lipase A 
catalysed resolution improved as the size of the alkyl substituent at C3 increased, the highest 
enantiopurity obtained being of (R)-1d at 81% ee (Table 5, entry 4).
40;41
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Hydrolase 
1d
1c
1b
1a
(R) - 1d 
(R) - 1c 
(S) - 1b 
(S) - 1a 
(S) - 1d 
(S) - 1c 
(R) - 1b 
(R) - 1a 
1d R=tBu 
 
1c R=iPr 
 
1b R=Et 
 
1a R=Me 
> 
> 
 
Hydrolase catalysed kinetic resolution of substituted phenyl butanoic acids (±)-1e-i 
 
A series of substituted phenyl butanoic acids were selected for investigation enabling 
exploration of the impact of substituents on the aryl ring on the efficiency of the kinetic 
bioresolution process. The substrates selected were ortho-, meta- and para-tolylbutanoic acid 
and para-methoxy, para-fluoro-phenyl butanoic acids enabling exploration of the electronic 
effect in addition to the impact of the position of substitution, (Figure 4). 
 
 
 
 
 
 
Figure 4. 
 
The outcome of the enzymatic screens are summarised in Tables 6-10. In each case effective 
kinetic bioresolution was achieved with Pseudomonas cepacia P1, Pseudomonas cepacia P2 
and Pseudomonas fluorescens resulting in successful hydrolysis of the S enantiomer with 
very similar outcomes to those seen with 3-phenylbutanoic acid (S)-1a indicating that the aryl 
substituent had little impact on the enzymatic hydrolysis.  
 
Table 6. Hydrolase-mediated hydrolysis of (±)-ethyl 3-(4-methylphenyl)butanoate (±)-3e  
 
Entry Enzyme Temp 
(°C) 
ee
a
 (%) Conversion
b
 
(%) 
E 
value
b
 Ester 3e Acid 1e 
1 Pseudomonas cepacia P1 30 98 (R) 99 (S) 50 >200 
2 Pseudomonas cepacia P2 30 99 (R) 96 (S) 51 >200 
3 Pseudomonas fluorescens 30 ≥99d (R) 95 (S) 51 >200 
4 Candida cyclindracea 30 -
c
 -
c
 0 -
c
 
5 Candida antarctica lipase 
A 
30 5 (R) 68 (S) 7 5.5 
6 Candida antarctica lipase 
B (immob) 
30 6 (S) 5 (R)  55 1.2 
 
a
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 99.5:0.5, flow rate 0.5 mL/min, 0 °C, λ=211 nm].  
b
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3e (ees) and product acid 1e (eep).
34
 
c
Reaction failed to proceed, no enantioselectivity observed. 
dWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
 Table 7. Hydrolase-mediated hydrolysis of (±)-ethyl 3-(3-methylphenyl)butanoate (±)-3f 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Enzyme  Temp 
(°C) 
ee
a,b
 (%) Conversion
c
 
(%) 
E 
value
c
 Ester 3f Acid 1f 
1 Pseudomonas cepacia 
P1 
30 88 (R)  96 (S)  48 143 
2 Pseudomonas cepacia 
P2 
30 ≥99e (R) 76 (S) 57 52 
3 Pseudomonas 
fluorescens 
30 96 (R) 97 (S) 50 >200 
4 Candida cyclindracea  30 -
d
 -
d
 0 -
d
 
5 Candida antarctica 
Lipase B (immob) 
30  ≥99e (S) 7 (R) 93 4.7 
 
a
Time for ester hydrolysis was 65 h with the exception of Candida cyclindracea catalysed 
hydrolysis which was 64 h. 
b
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 98:2, flow rate 0.25 mL/min, 0 °C, λ=209.8 nm].  
c
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3f (ees) and product acid 1f (eep).
34
 
d
Reaction failed to proceed, no enantioselectivity observed. 
eWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
Table 8. Hydrolase-mediated hydrolysis of (±)-ethyl 3-(2-methylphenyl)butanoate (±)-3g 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Enzyme Source Temp 
(°C) 
ee
a,b
 (%) Conversion
c
 
(%) 
E 
value
c
 Ester 3g Acid 1g  
1 Pseudomonas cepacia 
P1 
30 ≥99e (R)  99 (S)  50 >200 
2 Pseudomonas cepacia 
P2 
30 ≥99e (R) 80 (S) 56 65 
3 Pseudomonas 
fluorescens  
30 ≥99e (R) ≥99e (S) 50 >200 
4 Candida cyclindracea 30 -
d
 -
d
 0 -
d
 
5 Candida antarctica 
Lipase B (immob) 
30 90 (R) 46 (S)  66 7.7 
 
a
Time for ester hydrolysis was 67 h with the exception of Pseudomonas fluorescens catalysed 
hydrolysis which was 64 h. 
b
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 94:6, flow rate 0.25 mL/min, 0 °C, λ=209.8 nm].  
c
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3g (ees) and product acid 1g (eep).
34
 
d
Reaction failed to proceed, no enantioselectivity observed. 
eWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
Table 9. Hydrolase-mediated hydrolysis of (±)-ethyl 3-(4-methoxyphenyl)butanoate (±)-3h 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Enzyme  Temp 
(°C) 
 ee
a
 (%) Conversion
b
 
(%) 
E 
value
b
 Ester 3h Acid 1h 
1 Pseudomonas cepacia 
P1 
30 98 (R) 86 (S) 53 60 
2 Pseudomonas cepacia 
P2 
30 99 (R) 88 (S) 53 81 
3 Pseudomonas 
fluorescens 
30 ≥99d (R) 97 (S) 51 >200 
4 Candida Antarctica 
Lipase A 
30 4 (R)  48 (S) 8 3 
5 Candida cyclindracea 30 - - <10
c
 - 
6 Candida antarctica 
Lipase B (immob) 
30 66 (S) 7 (R) 90 1.9 
 
a
Determined by chiral HPLC analysis [Daicel Chiralcel OJ-H, hexane/i-PrOH (3%                                                     
trifluoroacetic acid) = 82:18, flow rate 0.25 mL/min, 0 °C, λ=216.9 nm].  
b
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3h (ees) and product acid 1h (eep).
34
 
c
Estimated by chiral HPLC. 
dWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
Table 10. Hydrolase-mediated hydrolysis of (±)-ethyl 3-(4-fluorophenyl)butanoate (±)-3i 
 
In all cases highly enantioenriched samples of the 3S acids and the 3R esters are readily 
obtained using the Pseudomonas biocatalysts, see Figure 5. 3-(4-Methylphenyl)butanoic acid 
(±)-1e had previously been resolved utilising Pseudomonas cepacia immobilized on ceramic 
particles to yield (S)-1e in 99% ee.
24
 The results obtained in this study utilising the free 
hydrolase, Table 6, entry 1, correlate strongly. The only significant effect of substituent seen 
in this series of substituted phenyl butanoic acids was with the para-F substrate (±)-3i where 
the conversion is increased relative to the other substrates resulting in a slight decrease in 
enantiopurity of the recovered acids. Use of the Candida cyclindracea biocatalyst with the 
substituted substrates was also explored; while Candida cyclindracea had resulted in some 
hydrolysis with the parent compound (±)-3a, very little conversion was seen with the 
substituted derivatives (Figure 5).  
 
 
 
 
 
 
 
Entry Enzyme Temp 
(°C) 
ee
a
 (%) Conversion
b
 
(%) 
E 
value
b
 Ester 3i Acid 1i 
1 Pseudomonas cepacia 
P1 
30 ≥99d (R) 84 (S) 54 59 
2 Pseudomonas cepacia 
P2 
30 ≥99d (R) 69 (S) 84 27 
3 Pseudomonas 
fluorescens 
30 ≥99d (R) 94 (S) 62 170 
4 Candida cyclindracea 30 3 (S) 25 (R) 11 1.7 
5 Candida antarctica 
Lipase B (immob) 
30  -
c
 -
c
 100 -
c
 
 
a
Determined by chiral HPLC analysis [Daicel Chiralcel AS-H column, Step gradient: 0 °C, 
λ=256 nm, hexane/iPrOH (3% trifluoroacetic acid), 0-30 min; 99.7:0.3, flow rate 1 mL/min. 
31 min; 94:6, flow rate 0.25 mL/min].  
b
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of 
substrate ester 3i (ees) and product acid 1i (eep).
34
 
c
Reaction went to 100% completion, no enantioselectivity observed. 
dWhen the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
  
Figure 5. Graph of enantiomeric ratio (E) versus hydrolase - kinetic bioresolutions for 1a and 
1e-i performed under standard aqueous conditions. 
 
Use of Candida antarctica Lipase B (immob) with the parent substrate (±)-1a provided 
access to the opposite enantiomeric series (Table 1, entry 19), albeit with a very high extent 
of reaction. In general similar reaction patterns were seen with the substituted substrates 
resulting in recovery of the (S)-esters 3e-f and 3h and the (R)-acids 1e-f and 1h. Notably, 
with the p-Me substrate (±)-3e the extent of reaction was less, resulting in a decrease in 
enantiopurity of the recovered ester (S)-3e, while with the para-F substrate both enantiomers 
are completely indiscriminately hydrolysed. Uniquely, the sense of enantioselection in 
Candida antarctica lipase B (immob) resolution of the o-Me substrate (±)-3g was the same as 
that seen with the Pseudomonas biocatalysts. Interestingly this biocatalyst was the one that 
was able to accommodate increased steric demand at the C3 position. The switch in 
enantioselection must be due to combined steric effects of the ortho-Me and 3-Me 
substituents possibly via conformational changes, (Figure 6). 
 
 
 
 
Figure 6. 
 
As summarised in Table 11, nine of the hydrolyse were scaled up to synthetic batches leading 
to isolations of acids 1a-i and esters 3a-i in excellent enantiopurity in most cases. 
Significantly, on scale up, the efficiencies and selectivities mirrored quite closely the 
outcomes seen in the analytical scale reactions summarised in Tables 1-10. Notably with the 
> 
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Hydrolases 
1a
1e
1f
1g
1h
1i
(S) enantiomer 
(R) enantiomer 
1a R=H 
 
1e R=p-Me 
 
1f R=m-Me 
 
1g R=o-Me 
 
1h R=p-OMe 
 
1i R=p-F 
 
 > 
para-F series the acid (S)-1i was recovered in excellent enantiopurity in contrast to the small 
scale reaction (Table 10, entry 3). With the 3-aryl butanoic acids the products of the 
biocatalysis were readily isolated by extraction with ethyl acetate followed by 
chromatographic separation of the acids and esters. With the bulkier 3-alkyl substituents, 
chromatography was less effective. In practice the ester was recovered first by heptane 
extraction of the biotransformation mixture, then subsequent acidification and extraction with 
ethyl acetate provided the acids (R)-1b and (S)-1c-d. Each of the products were characterised 
by 
1
H NMR and chiral HPLC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 11. Synthetic scales of hydrolase-mediated hydrolysis of (±)-3a-i 
 
 
 
 
 
 
 
 
 
 
Entry Ester substrate Enzyme ee
a 
(%) Conversion
b
 
(%) 
E 
value
b
 
 R
1
 R
2
  Ester Acid   
1 3a H CH3 Pseudomonas 
fluorescens 
99 
(R)-3a 
98  
(S)-1a 
50 >200 
2 3b H CH2CH3 Candida 
antarctica 
lipase B 
(immob)
c
 
65 
(S)-3b 
90 
(R)-1b 
42 37 
3 3c H CH(CH3)2 Candida 
antarctica 
lipase B 
(immob) 
26  
(R)-3c 
98 
(S)-1c 
21 127 
4 3d H C(CH3)3 Candida 
antarctica 
lipase B 
(immob) 
12 
(R)-3d 
99  
(S)-1d 
11 >200 
5 3e p-CH3 CH3 Pseudomonas 
cepacia P1 
97 
(R)-3e 
≥99d 
(S)-1e 
49 >200 
6 3f m-CH3 CH3 Pseudomonas 
fluorescens 
94  
(R)-3f 
≥99d 
(S)-1f 
49 >200 
7 3g o-CH3 CH3 Pseudomonas 
fluorescens 
98 
(R)-3g 
≥99d 
(S)-1g 
50 >200 
8 3h p-OCH3 CH3 Pseudomonas 
fluorescens 
99 
(R)-3h 
97 
(S)-1h 
51 >200 
9 3i p-F CH3 Pseudomonas 
fluorescens 
≥99d 
(R)-3i 
97 
(S)-3i 
51 >200 
 
a
For chiral HPLC conditions see details on relevant Tables 1-10. 
b
Conversion and the enantiomeric ratio E was calculated from enantiomeric excess of substrate 
ester 3a-i (ees) and product acid 1a-i (eep).
34
 
c
17% v/v dioxane co-solvent was added, see experimental for further information.  
d
When the second enantiomer is not observed enantiomeric excess is stated as ≥99% ee.  
 
Conclusion 
 
In this study, a series of 3-aryl alkanoic acids (±)-1a-i were successfully resolved with 
enantiopurity ≥94% ee via hydrolase catalysed kinetic hydrolysis of the corresponding ethyl 
esters. It was apparent upon resolving acids (±)-1a-d that a large reduction in reaction rate 
and enantioselectivity was observed once the moiety at the C3 stereogenic centre increased in 
size greater than a methyl. Despite this, the highest obtained enantiopurities of hydrolase 
catalysed bioresolutions of 3-aryl alkanoic acids (±)-1a-d are reported through optimisation 
of reaction conditions and a viable route to both enantiomers has been identified. 
Furthermore, substituents on the phenyl ring, acids (±)-1e-i were determined to have limited 
effect on the excellent enantioselectivities attainable concluding that the hydrolases can 
tolerate increased steric demand in the aryl group more readily than in the 3-alkyl group. 
Significantly nine of these experiments were conducted on a synthetic scale leading to 
isolation of acids 1a-i and esters 3a-i in excellent enantiopurity in most cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental 
 
All solvents were distilled prior to use as follows: dichloromethane was distilled from 
phosphorus pentoxide and ethyl acetate was distilled from potassium carbonate. Ethanol was 
distilled from magnesium in the presence of iodine and stored over 3 Å molecular sieves. 
Hexane was distilled prior to use. Tetrahydrofuran was distilled from sodium and 
benzophenone. Molecular sieves were activated by heating at 150 ºC overnight. Organic 
phases were dried using anhydrous magnesium sulphate. Infrared spectra were recorded as 
thin films on sodium chloride plates for oils or as potassium bromide (KBr) discs for solids 
on a Perkin Elmer Paragon 1000 FT-IR spectrometer. 
 
1
H (300 MHz) and 
13
C (75.5 MHz) NMR spectra were recorded on a Bruker Avance 300 
MHz NMR spectrometer. 
1
H (400 MHz) NMR spectra were recorded on a Bruker Avance 
400 MHz NMR spectrometer. All spectra were recorded at room temperature (~20 °C) in 
deuterated chloroform (CDCl3) unless otherwise stated using tetramethylsilane (TMS) as an 
internal standard. Chemical shifts (H & C) are reported in parts per million (ppm) relative to 
TMS and coupling constants are expressed in Hertz (Hz).  
 
Low resolution mass spectra were recorded on a Waters Quattro Micro triple quadrupole 
spectrometer in electrospray ionization (ESI) mode using 50% water/acetonitrile containing 
0.1% formic acid as eluant; samples were made up in acetonitrile. High resolution mass 
spectra (HRMS) were recorded on a Waters LCT premier Time of Flight spectrometer in 
electrospray ionization (ESI) mode using 50% water/acetonitrile containing 0.1% formic acid 
as eluant; samples were made up in acetonitrile. 
 
Elemental analysis were performed by the Microanalysis Laboratory, National University of 
Ireland, Cork, using Perkin-Elmer 240 and Exeter Analytical CE440 elemental analysers. 
Melting points were carried out on a uni-melt Thomas Hoover Capillary melting point 
apparatus and are uncorrected. Wet flash chromatography was performed using Kieselgel 
silica gel 60, 0.040-0.063 mm (Merck). Thin layer chromatography (TLC) was carried out on 
precoated silica gel plates (Merck 60 PF254). Visualisation was achieved by UV (254nm) light 
detection and bromocresol green staining. 
 
Optical rotations were measured on a Perkin-Elmer 141 polarimeter at 589 nm in a 10 cm 
cell; concentrations (c) are expressed in g/100 mL.      
   is the specific rotation of a 
compound and is expressed in units of 10
1
 deg cm
2
 g
1
. The hydrolases used for these 
biotransformations were obtained from Almac Sciences. All reagents are analytical grade and 
purchased from Sigma Aldrich chemical company. All enzymatic reactions were performed 
on a VWR Incubating Mini Shaker 4450. Enantiomeric purity of acids 1a-h and esters 3a-h 
were determined by chiral HPLC analysis on a Chiralcel OJ-H column (5×250 mm), 
enantiomeric purity of acid 1i and ester 3i were determined on a Chiralcel AS-H column 
(5×250 mm) purchased from Daicel Chemical Industries, Japan. Mobile phase, flow rate, 
detection wavelength and temperature are stated in the appropriate Table 1-10. HPLC 
analysis was performed on a Waters alliance 2690 separations module with a PDA detector. 
All solvents employed were of HPLC grade.  Bulb to bulb distillations were carried out on an 
Aldrich Kugelrohr apparatus and the oven temperature is given as the boiling point of the 
substrate. (±)-3-(p-Fluorophenyl)butanoic acid (±)-1i and (±)-ethyl 3-(p-
fluorophenyl)butanoate (±)-3i were prepared according to the procedure described by 
Speranza.
32
 
 
Synthesis of Carboxylic Acids 
 
(±)-3-Phenylpentanoic acid (±)-1b
28;31;42
  
Ethyl magnesium bromide was freshly prepared from magnesium (2.85 g, 117
 
mmol) and 
iodine (catalytic amount) in diethyl ether (30 mL) and ethyl bromide (8.7 mL, 117 mmol) in 
diethyl ether (30 mL) at 0 C under nitrogen and the mixture was stirred for 0.5 h at 0 ºC. 
Cinnamic acid (5.00 g, 33.75 mmol) was added portionwise while stirring at 0 C, then the 
reaction mixture was heated under reflux for 3 h. The reaction mixture was subsequently 
cooled to room temperature and carefully poured onto aqueous hydrochloric acid (10%, ~100 
mL) and ice (~65 g). The layers were separated and the aqueous layer was washed with 
diethyl ether (3 × 50 mL). The combined organic layer was washed with hydrochloric acid 
(10%, 50 mL), water (50 mL), brine (50 mL), dried, filtered and concentrated under reduced 
pressure to give the crude acid (±)-1b (5.54 g, 92%) as an orange oil which was used without 
further purification. νmax/cm
-1
 (film) 2965 (OH), 1708 (CO), 1603, 1495, 1454; H (400 MHz) 
0.79 [3H, t, J 7.4, C(5)H3], 1.46–1.83 [2H, m, C(4)H2], 2.60 [1H, dd, A of ABX, JAB 15.6, 
JAX 7.9, one of C(2)H2], 2.68 [1H, dd, B of ABX, JAB 15.6, JBX 7.1, one of C(2)H2], 2.89–
3.08 [1H, m, X of ABX, C(3)H], 7.09–7.38 (5H, m, ArH). 
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
Aqueous potassium hydroxide (20%, 35 ml) was added to a sample of 3-phenylpentanoyl 
chloride (±)-2b (0.5 g, 2.6 mmol) under nitrogen. The reaction mixture was heated to reflux 
and stirred under reflux overnight. The reaction mixture was then cooled to room temperature 
and acidified to pH 1 with aqueous hydrochloric acid (10%), which resulted in a white 
precipitate. The suspension was then extracted with dichloromethane (3 × 50 ml), and the 
combined organic layers where washed with brine (100 ml), dried, filtered and concentrated 
under reduced pressure to give the acid (±)-1b (0.428 g, 92%) as a cream solid, m.p.59-62 ºC 
(Lit.,
31
 60-61 ºC) and with spectral characteristics identical to those described above.    
 
(±)-4-Methyl-3-phenylpentanoic acid (±)-1c
28;42
  
This was prepared following the procedure described for (±)-1b from isopropyl magnesium 
bromide [freshly prepared from magnesium (2.70 g,  111 mmol) and iodine (catalytic 
amount) in diethyl ether (30 mL), and isopropyl bromide (11.25 mL, 120 mmol) in diethyl 
ether (30 mL)] and cinnamic acid (5.00 g, 33.75 mmol) to give the crude acid (±)-1c (5.38 g, 
83%) as an orange oil, which was used without further purification. vmax/cm
-1
 (film) 2963 
(OH), 1709 (CO), 1602, 1495, 1454; H (400 MHz) 0.74, 0.92 [2 × 3H, 2 × d, J 6.7, J 6.7, 
C(4)HCH3, C(5)H3], 1.79–1.91 [1H, m, C(4)H], 2.60 [1H, dd, A of ABX, JAB 15.5, JAX 9.5, 
one of C(2)H2], 2.72–2.92 [2H, m, BX of ABX, one of C(2)H2, C(3)H], 7.10–7.28 (5H, m, 
ArH). 
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 50 mL) and 4-methyl-3-phenylpentanoyl chloride (±)-2c (1.00 g, 4.75 
mmol) to give the acid (±)-1c (900 mg, 99%) as a cream, white solid, m.p. 48-50 C (Lit.,28 
46-48 ºC) and with spectral characteristics identical to those described above. 
 
(±)-4,4-Dimethyl-3-phenylpentanoic acid (±)-1d
28;31
  
This was prepared following the procedure described for (±)-1b, from t-butyl magnesium 
chloride (2 M in diethyl ether, 106 mL, 212 mmol) and cinnamic acid (7.85 g, 52.98 mmol) 
to give the crude acid (±)-1d (8.63 g, 79%) as a yellow solid, which was used without further 
purification. max/cm
−1
 (KBr) 2955 (OH), 1726 (CO), 1638, 1453; H (400 MHz) 0.87 [9H, s, 
C(CH3)3], 2.73 [1H, dd, A of ABX, JAB 15.8, JAX 10.8, one of C(2)H2], 2.81 [1H, dd, B of 
ABX, JAB 15.8, JBX 4.5, one of C(2)H2], 2.93 [1H, dd, X of ABX, JAX 10.8, JBX 4.5, C(3)H], 
7.07–7.33 (5H, m, ArH).  
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 8 mL) and 4,4-dimethyl-3-phenylpentanoyl chloride (±)-2d (214 mg, 0.95 
mmol) to give the acid (±)-1d (153 mg, 78%) as a white solid, m.p. 108-110 C (Lit.,28 114–
116 C) and with spectral characteristics identical to those described above. 
 
(±)-3-(4-Methylphenyl)butanoic acid (±)-1e
42
  
This was prepared from p-tolyl magnesium bromide [freshly prepared from magnesium (10 
g, 411 mmol) and iodine (catalytic amount) in diethyl ether (80 mL), and 4-bromotoluene 
(51.6 mL, 419 mmol) in diethyl ether (60 mL)] and crotonic acid (12.00 g, 139 mmol). The 
reaction mixture, containing the product (±)-1e and the Wurtz coupling product, was acidified 
to pH 2 and the aqueous layer washed with diethyl ether (2 × 100 mL). The combined diethyl 
ether extracts were washed with sodium hydroxide (20%, 2 × 100 mL) the aqueous layer was 
acidified to pH 1 with conc. hydrochloric acid and extracted with diethyl ether (3 × 100 mL). 
The organic layer was dried, filtered and concentrated under reduced pressure to give the 
crude acid (±)-1e as a viscous yellow oil (21.19 g, 86%) which was used without further 
purification. vmax/cm
-1 
(film) 2926 (OH),
 
1704 (CO), 1515, 1455, 1416; δH (300 MHz) 1.30 
[3H, d, J 7.0, C(4)H3], 2.31 [3H, s, C(4')CH3], 2.55 [1H, dd, A of ABX, JAB 15.5, JAX 8.2, one 
of C(2)H2], 2.65 [1H, dd, B of ABX, JAB 15.5, JBX 6.9, one of C(2)H2], 3.18-3.30 [1H, m, X 
of ABX, C(3)H], 7.11 (4H, s, ArH). 
  
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 8 mL) and 3-(4-methylphenyl)butanoyl acid chloride (±)-2e (200 mg, 1.02 
mmol) to give the acid (±)-1e (152 mg, 83%) as a white solid, m.p. 91-92 C (Lit.,43 87-88 
C) and with spectral characteristics identical to those described above. 
 
(±)-3-(3-Methylphenyl)butanoic acid (±)-1f
44
  
This was prepared following the procedure described for (±)-1e from 3-tolyl magnesium 
bromide [freshly prepared from magnesium (4.24 g, 174 mmol) and iodine (catalytic amount) 
in diethyl ether (40 mL), and 3-bromotoluene (21 mL, 173 mmol) in diethyl ether (40 mL)] 
and crotonic acid (5.00 g, 58 mmol) to give the crude acid (±)-1f (8.55 g, 83%) as an orange 
oil, which was used without further purification. vmax/cm
-1 
(film) 2971 (OH),
 
1718 (CO), 
1608, 1490, 1455; δH (300 MHz) 1.30 [3H, d, J 7.0, C(4)H3], 2.33 [3H, s, C(3')CH3], 2.55 
[1H, dd, A of ABX, JAB 15.5, JAX 8.4, one of C(2)H2], 2.66 [1H, dd, B of ABX, JAB 15.5, JBX 
6.7, one of C(2)H2], 3.14-3.31 [1H, m, X of ABX, C(3)H], 6.91–7.22 (4H, m, ArH). 
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 150 mL) and 3-(3-methylphenyl)butanoyl chloride (±)-2f (4.59 g, 23.36 
mmol) to give the acid (±)-1f (2.87 g, 69%) as a clear oil and with spectral characteristics 
identical to those described above. 
 
(±)-3-(2-Methylphenyl)butanoic acid (±)-1g
45
  
This was prepared following the procedure described for (±)-1e from 2-tolyl magnesium 
bromide [freshly prepared from magnesium (4.22 g, 174 mmol) and iodine (catalytic amount) 
in diethyl ether (40 mL), and 2-bromotoluene (21 mL, 175 mmol) in diethyl ether (40 mL)] 
and crotonic acid (5.00 g, 58 mmol) to give the crude acid (±)-1g (8.21 g, 79%) as an orange 
oil, which was used without further purification. vmax/cm
-1 
(film) 2973 (OH),
 
1712 (CO), 
1605, 1492, 1460; δH (400 MHz) 1.27 [3H, d, J 6.9, C(4)H3], 2.36 [3H, s, C(2')CH3], 2.55 
[1H, dd, A of ABX, JAB 15.7, JAX 8.6, one of C(2)H2], 2.67 [1H, dd, B of ABX, JAB 15.6, JBX 
6.3, one of C(2)H2], 3.45-3.58 [1H, m, X of ABX, C(3)H], 7.06–7.27 (4H, m, ArH). 
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 100 mL) and 3-(2-methylphenyl)butanoyl chloride (±)-2g (3.10 g, 15.75 
mmol) to give the acid (±)-1g (2.20 g, 78%) as a yellow solid, m.p. 46-48 ºC (Lit.,
45
 46-47 
C) and with spectral characteristics identical to those described above. 
 
(±)-2-(4-Methoxyphenyl)butanoic acid (±)-1h
46;47
  
This was prepared following the procedure described for (±)-1e from p-methoxyphenyl 
magnesium bromide [freshly prepared from magnesium (10.22 g, 420 mmol) and iodine 
(catalytic amount) in diethyl ether (80 mL), and 4-bromoanisole (52 mL, 415 mmol) in 
diethyl ether (100 mL)] and crotonic acid (12.00 g, 139 mmol) to give the crude acid (±)-1h 
(19.17 g, 71%) as a yellow oil, which was used without further purification. vmax/cm
-1 
(film) 
2963 (OH),
 
1711 (CO), 1611, 1511, 1458; δH (400 MHz) 1.29 [3H, d, J 7.0, C(4)H3], 2.54 
[1H, dd, A of ABX, JAB 15.4, JAX 8.1, one of C(2)H2], 2.62 [1H, dd, B of ABX, JAB 15.4, JBX 
7.0, one of C(2)H2], 3.17-3.29 [1H, m, X of ABX, C(3)H], 3.77 (3H, s, OCH3), 6.79-6.88 
[2H, m, C(3’)H, C(5’)H], 7.11-7.16 [2H, m, C(2’)H, C(6’)H].  
 
Preparation of the analytically pure acid by basic hydrolysis of the corresponding acid 
chloride.  
This was prepared following the procedure described for (±)-1b, from aqueous potassium 
hydroxide (20%, 8 mL) and 3-(4-methoxyphenyl)butanoyl chloride (±)-2h (200 mg, 0.94 
mmol) to give the acid (±)-1h (114 mg, 62%) as a cream solid, m.p. 66-68 C (Lit.,46 67-69 
C) and with spectral characteristics identical to those described above. 
 
Synthesis of Acid Chlorides 
 
The acid chlorides were generally prepared from crude acids. The yield given below is the 
yield of acid chloride over two steps calculated from the unsaturated precursor for the acid. 
 
(±)-3-Phenylpentanoyl chloride (±)-2b
28
  
3-Phenylpentanoic acid (±)-1b (5.01 g, 28.13 mmol) in thionyl chloride (16 mL, 225 mmol) 
was heated under reflux for 3 h while stirring under nitrogen. Excess thionyl chloride was 
evaporated under reduced pressure to give the acid chloride (±)-2b as a brown oil. 
Purification by vacuum distillation gave the acid chloride (±)-2b (2.07 g, 31%) as a bright 
yellow oil; b.p. 72-76C at 0.09 mmHg (Lit.,28 113–115 C at 0.5 mmHg); vmax/cm
-1
 (film) 
1799 (CO), 1604, 1495, 1454; H (400 MHz) 0.80 [3H, t, J 7.4, C(5)H3], 1.58–1.80 [2H, m, 
C(4)H2], 3.04–3.23 [3H, m, C(2)H2, C(3)H], 7.16–7.34 (5H, m, ArH). 
 
(±)-4-Methyl-3-phenylpentanoyl chloride (±)-2c
28
  
This was prepared following the procedure described for (±)-2b, from crude 4-methyl-3-
phenylpentanoic acid (±)-1c (5.28 g, 27.46 mmol) and thionyl chloride (16 mL, 220 mmol) to 
give the crude acid chloride (±)-2c as a brown oil.  Purification by distillation gave the acid 
chloride (±)-2c (2.54 g, 36%) as a clear oil; b.p. 78-80 C at 0.15 mmHg (Lit.,28 90–94 C at 
0.08 mmHg); max/cm
-1
 (film) 1799 (CO), 1602, 1495, 1454; H (400 MHz) 0.76, 0.97 [2 × 
CH3, 2 × d, J 6.7, J 6.7, C(4)HCH3, C(5)H3], 1.82–1.94 [1H, m, C(4)H], 2.92–2.98 [1H, m, X 
of ABX, C(3)H], 3.18 [1H, dd, A of ABX, JAB 16.4, JAX 9.7, one of C(2)H2], 3.34 [1H, dd, B 
of ABX, JAB 16.4, JAX 5.2, one of C(2)H2], 7.09–7.35 (5H, m, ArH) 
 
(±)-4,4-Dimethyl-3-phenylpentanoyl chloride (±)-2d
28
  
This was prepared following the procedure described for (±)-2b, from crude 4,4-dimethyl-3-
phenylpentanoic acid (±)-1d (8.63 g 42 mmol) and thionyl chloride (24 mL, 335 mmol) to 
give the crude acid chloride (±)-2d as a brown oil.  Purification by distillation gave the acid 
chloride (±)-2d (5.04 g, 54%) as a bright yellow solid, b.p. 84-86 C at 0.12 mmHg (Lit.,28 
123–125 C at 0.1 mmHg); vmax/cm
-1
 (KBr) 1793 (CO), 1601, 1494, 1453; H (400 MHz) 
0.91 [9H, s, C(CH3)3], 3.04 [1H, dd, X of ABX, J 8.9, 6.1, C(3)H], 3.26–3.39 [2H, m, 
C(2)H2], 7.14–7.31 (5H, m, ArH).  
 
 
 
 
 
(±)-3-(4-Methylphenyl)butanoyl chloride (±)-2e
48
  
This was prepared following the procedure described for (±)-2b, from crude 3-(4-
methylphenyl)butanoic acid (±)-1e (21.19 g, 119 mmol) and thionyl chloride (86 mL, 1190 
mmol) to give the crude acid chloride (±)-2e as a black oil. Purification by distillation gave 
the acid chloride (±)-2e (12.09 g, 44%) as a dark orange oil, b.p. 66–68 C at 0.2 mmHg 
(Lit.,
48 
127 C at 0.20 mmHg); vmax/cm
-1
 (film) 1800 (CO), 1649, 1516, 1455; δH (300 MHz) 
1.32 [3H, d, J 7.0, C(4)H3], 2.32 [3H, s, C(4')CH3], 3.07 [1H, dd, A of ABX, JAB 16.4, JAX 
7.9, one of C(2)H2], 3.17 [1H, dd, B of ABX, JAB 16.4, JBX 6.4, one of C(2)H2], 3.27–3.38 
[1H, m, X of ABX, C(3)H], 7.04–7.21 (4H, m, ArH). 
 
(±)-3-(3-Methylphenyl)butanoyl chloride (±)-2f  
This was prepared following the procedure described for (±)-2b, from crude 3-(3-
methylphenyl)butanoic acid (±)-1f (8.55 g, 47.97 mmol) and thionyl chloride (28 mL, 384 
mmol) to give the crude acid chloride (±)-2f as a black oil. Purification by distillation gave 
the acid chloride (±)-2f (4.59 g, 40%) as a bright yellow oil, b.p. 77–80 C at 0.2 mmHg; 
vmax/cm
-1
 (film) 1800 (CO), 1608, 1491, 1456; δH (300 MHz) 1.32 [3H, d, J 6.9, C(4)H3], 
2.33 [3H, s, C(3')CH3], 3.06 [1H, dd, A of ABX, JAB 16.5, JAX 8.0, one of C(2)H2], 3.17 [1H, 
dd, B of ABX, JAB 16.5, JBX 6.5, one of C(2)H2], 3.25–3.36 [1H, m, X of ABX, C(3)H], 
6.98–7.05 [3H, m, C(4’)H, C(5’)H, C(6’)H, ArH], 7.17-7.22 [1H, m, C(2’)H, ArH].  
 
(±)-3-(2-Methylphenyl)butanoyl chloride (±)-2g  
This was prepared following the procedure described for (±)-2b, from crude 3-(2-
methylphenyl)butanoic acid (±)-1g (8.21 g, 46 mmol) and thionyl chloride (27 mL, 368 
mmol) to give the crude acid chloride (±)-2g as a black oil. Purification by distillation gave 
the acid chloride (±)-2g (4.68 g, 41%) as a bright yellow oil, b.p. 64–66 C at 0.09 mmHg; 
vmax/cm
-1
 (film) 1801 (CO), 1605, 1492, 1459; δH (400 MHz) 1.27 [3H, d, J 7.0, C(4)H3], 
2.35 [3H, s, C(2')CH3], 3.03 [1H, dd, A of ABX, JAB 16.6, JAX 8.2, one of C(2)H2], 3.16 [1H, 
dd, B of ABX, JAB 16.6, JBX 6.3, one of C(2)H2], 3.54–3.63 [1H, m, X of ABX, C(3)H], 
7.07–7.28 (4H, m, ArH). 
 
(±)-3-(4-Methoxyphenyl)butanoyl chloride (±)-2h
46
  
This was prepared following the procedure described for (±)-2b, from crude 3-(4-
methoxyphenyl)butanoic acid (±)-1h (19.17 g, 99 mmol), thionyl chloride (57 mL, 790 
mmol) to give the crude acid chloride (±)-2h as a black oil. Purification by distillation gave 
the acid chloride (±)-2h (8.69 g, 29%) as a orange brown oil, b.p. 102–110 C at 0.35 mmHg 
(Lit.,
46
 100 °C at 0.5 mmHg); vmax/cm
-1
 (film) 1790 (CO), 1614, 1515, 1463; δH (400 MHz) 
1.32 [3H, d, J 7.0, C(4)H3], 3.07 [1H, dd, A of ABX, JAB 16.4, JAX 7.8, one of C(2)H2], 3.15 
[1H, dd, B of ABX, JAB 16.4, JBX 6.8, one of C(2)H2], 3.27–3.36 [1H, m, X of ABX, C(3)H],  
3.78 (3H, s, OCH3), 6.84-6.87 [2H, m, C(3’)H, C(5’)H], 7.11-7.15 [2H, m, C(2’)H, C(6’)H].  
  
 
 
 
 
 
Synthesis of Ethyl Esters 
 
(±)-Ethyl 3-phenylbutanoate (±)-3a
49
  
Sulfuric acid (1.0 mL, 18.76 mmol) was added to a solution of 3-phenylbutanoic acid (±)-1a 
(998 mg, 6.08 mmol) in absolute ethanol (20 mL) and refluxed overnight. Excess ethanol was 
evaporated under reduced pressure. The crude product was dissolved in dichloromethane (45 
mL) and washed with water (2 × 45 mL), sat. NaHCO3 (2 × 45 mL), brine (50 mL), dried, 
filtered and concentrated under reduced pressure to give the crude ester (±)-3a (972 mg) as a 
clear oil. Purification by chromatography on silica gel using hexane/ethyl acetate 60/40 as 
eluant gave the pure ester (±)-3a (909 mg, 78%) as a clear oil; vmax/cm
-1
 (film) 2969 (CH), 
1733 (CO), 1604, 1495,1454 (Ar), 1174 (C-O); H (400 MHz) 1.17 (3H, t, J 7.1, OCH2CH3), 
1.30 [3H, d, J 7.0, C(4)H3], 2.53 [1H, dd, A of ABX, JAB 15.0, JAX 8.2, one of C(2)H2], 2.61 
[1H, dd, B of ABX, JAB 15.0, JBX 7.0, one of C(2)H2], 3.23-3.32 [1H, sym. m, X of ABX, 
C(3)H], 4.08 (2H, q, J 7.1, OCH2CH3), 7.17–7.34 (5H, m, ArH).  
 
(±)-Ethyl 3-phenylpentanoate (±)-3b
50
  
3-Phenylpentanoyl chloride (±)-2b (1.96 g, 9.96 mmol) in dichloromethane (10 mL) was 
added dropwise to a solution of triethylamine (1.7 mL, 11.9 mmol), dichloromethane (10 mL) 
and distilled ethanol (1.45 mL, 24.9 mmol), at 0 °C. The reaction mixture was stirred at room 
temperature overnight. The crude product was dissolved in dichloromethane (30 mL) and 
washed with water (2 × 50 mL), HCl (10%, 2 × 50 mL), brine (100 mL) dried, filtered and 
concentrated under reduced pressure to give the crude ester (±)-3b (1.64 g) as a deep orange 
oil. Purification by chromatography on silica gel using hexane/ether  97/3 as eluant gave the 
pure ester (±)-3b (1.49 g, 72%) as a clear oil; vmax/cm
-1
 (film) 2967 (CH), 1735 (CO), 1603, 
1493, 1454 (Ar), 1167 (C-O); H (400 MHz) 0.79 [3H, t, J 7.4, C(5)H3], 1.13 (3H, t, J 7.1, 
OCH2CH3), 1.55-1.76 [2H, m, C(4)H2], 2.55 [1H, dd, A of ABX, JAB 15.0, JAX 8.2, one of 
C(2)H2], 2.63 [1H, dd, B of ABX, JAB 15.0, JBX 7.1, one of C(2)H2], 2.96-3.04 [1H, m, X of 
ABX, C(3)H], 4.02 (2H, q, J 7.1, OCH2CH3), 7.17-7.30 (5H, m, ArH).   
 
(±)-Ethyl 4-methyl-3-phenylpentanoate (±)-3c
51
  
This was prepared following the procedure described for (±)-3b, from 4-methyl-3-
phenylpentanoyl chloride (±)-2c (2.43 g, 11.52 mmol), triethylamine (1.9 mL, 13.82 mmol), 
dichloromethane (10 mL) and distilled ethanol (1.7 mL, 28.79 mmol) to yield the crude ester 
(±)-3c (2.02 g) as a yellow orange oil. Purification by chromatography on silica gel using 
hexane/ether 97/3 as eluant gave the pure ester (±)-3c (1.6 g, 63%) as a clear oil. vmax/cm
-1
 
(film) 2961 (CH), 1736 (CO), 1602, 1494, 1453 (Ar), 1162 (C-O); H (400 MHz) 0.75, 0.95 
[2 × 3H, 2 × d, J 6.7, J 6.7, C(4)HCH3, C(5)H3], 1.05 (3H, t, J 7.1, OCH2CH3) 1.79–1.91 
[1H, sym m, C(4)H], 2.58 [1H, dd, A of ABX, JAB 14.9, JAX 9.9, one of C(2)H2], 2.77 [1H, 
dd, B of ABX, JAB 14.9, JBX 5.6, one of C(2)H2], 2.85–2.91 [1H, m, X of  ABX, C(3)H], 3.95 
(2H, q, J 7.1, OCH2CH3), 7.14–7.28 (5H, m, ArH). 
 
(±)-Ethyl 4,4-dimethyl-3-phenylpentanoate (±)-3d
52
  
This was prepared following the procedure described for (±)-3b, from 4,4-dimethyl-3-
phenylpentanoyl chloride (±)-2d (5.04 g, 22.4 mmol), triethylamine (3.8 mL, 26.9 mmol), 
dichloromethane (30 mL) and distilled ethanol (3.3 mL, 56.1 mmol) to yield the crude ester 
(±)-3d (3.81 g) as a bright yellow oil. Purification by chromatography on silica gel using 
hexane/ether 97/3 as eluant gave the pure ester (±)-3d (2.94 g, 56%) as pale yellow oil. 
vmax/cm
-1
 (film) 2965 (CH), 1737 (CO), 1602, 1454 (Ar), 1152 (C-O); H (400 MHz) 0.89 
[9H, s, C(CH3)3], 0.99 (3H, t, J 7.1 OCH2CH3) 2.71 [1H, dd, A of ABX, JAB 15.2, JAX 10.9, 
one of C(2)H2], 2.79 [1H, dd, B of ABX, JAB 15.2, JBX 5.0, one of C(2)H2], 2.98 [1H, dd, X 
of ABX, JAX 10.9, JBX 5.0, C(3)H], 3.85-3.97 (2H, m, OCH2CH3), 7.13–7.26 (5H, m, ArH).  
 
(±)-Ethyl 3-(4-methylphenyl)butanoate (±)-3e
24
  
This was prepared following the procedure described for (±)-3b, from 3-(4-
methylphenyl)butanoyl chloride (±)-2e (12.09 g, 61.47 mmol), triethylamine (10.28 mL, 
73.76 mmol), dichloromethane (25 mL) and distilled ethanol (8.9 mL, 153.7 mmol) to yield 
the crude ester (±)-3e (9.41 g) as a deep orange oil. Purification by chromatography on silica 
gel using hexane/ether 97/3 as eluant gave the pure ester (±)-3e (7.84 g, 62%) as a clear oil. 
vmax/cm
-1
 (film) 2967 (CH), 1732 (CO), 1516, 1456 (Ar), 1166 (C-O); H (400 MHz) 1.19 
(3H, t, J 7.1, OCH2CH3), 1.28 [3H, d, J 7.0, C(4)H3], 2.32 [3H, s, C(4')CH3], 2.51 [1H, dd, A 
of ABX, JAB 15.0, JAX 8.2, one of C(2)H2], 2.59 [1H, dd, B of ABX, JAB 15.0, JBX 7.0, one of 
C(2)H2], 3.20–3.29 [1H, m, X of ABX, C(3)H], 4.07 (2H, q, J 7.2, OCH2CH3), 7.11 (4H, s, 
ArH). 
 
(±)-Ethyl 3-(3-methylphenyl)butanoate (±)-3f  
This was prepared following the procedure described for (±)-3b, from 3-(3-
methylphenyl)butanoyl chloride (±)-2f (7.32 g, 37.2 mmol), triethylamine (6.2 mL, 44.64 
mmol), dichloromethane (30 mL) and distilled ethanol (5.4 mL, 92.99 mmol) to yield the 
crude ester (±)-3f (6.53 g) as a dark brown oil. Purification by chromatography on silica gel 
using hexane/ether 97/3 as eluant gave the pure ester (±)-3f (5.16 g, 67%) as a clear oil. 
(Found C, 75.13; H 8.77. C13H18O2 requires C, 75.69; H, 8.80%); vmax/cm
-1
 (film) 2968 (CH), 
1733 (CO), 1608, 1461 (Ar), 1177 (C-O); δH (400 MHz) 1.18 (3H, t, J 7.1, OCH2CH3), 1.28 
[3H, d, J 7.0, C(4)H3], 2.32 [3H, s, C(3')CH3], 2.51 [1H, dd, A of ABX, JAB 15.0, JAX 8.3, 
one of C(2)H2], 2.59 [1H, dd, B of ABX, JAB 15.0, JBX 6.9, one of C(2)H2], 3.19–3.28 [1H, 
m, X of ABX, C(3)H], 4.07 (2H, q, J 7.1, OCH2CH3), 6.97–7.05 [3H, m, C(4’)H, C(5’)H, 
C(6’)H, ArH], 7.13-7.19 [1H, m, C(2’)H, ArH]. δC (75.5 MHz) 14.2, 21.5, 21.8 [3 x CH3, 
C(4)H3, OCH2CH3, C(3’)CH3], 36.5 [CH, C(3)H], 43.0 [CH2, C(2)H2], 60.3 [CH2, 
OCH2CH3], 123.7, 127.1, 127.6, 128.4 (4 x CH, aromatic CH), 138.0, 145.8 (2 x C, aromatic 
C), 172.5 [C, C(1)]. HRMS (ES+): Exact mass calculated for C13H18O2 [M+H]
+
 207.1385. 
Found 207.1390; m/z (ES+) 207.1 {[(C13H18O2)+H]
+
, 57%}, 202.1 (100%), 161.1 
{[(C11H13O)-C2H5O]
-
, 60%}, 151.0 (23%), 141.0 (7%).   
 
(±)-Ethyl 3-(2-methylphenyl)butanoate (±)-3g  
This was prepared following the procedure described for (±)-3b, from 3-(2-
methylphenyl)butanoyl chloride (±)-2g (4.68 g, 23.79 mmol), triethylamine (4 mL, 28.54 
mmol), dichloromethane (20 mL) and distilled ethanol (3.5 mL, 59.46 mmol) to yield the 
crude ester (±)-3g (2.85 g) as a yellow oil. Purification by chromatography on silica gel using 
hexane/ether 97/3 as eluant gave the ester (±)-3g (2.5 g, 67%) as a clear oil. Further 
purification by distillation gave the ester (±)-3g (2.14 g, 44%) as a clear oil, b.p. 96°C at 0.06 
mmHg; (Found C, 75.43; H 8.67. C13H18O2 requires C, 75.69; H, 8.80%); vmax/cm
-1
 (film) 
2975 (CH), 1733 (CO), 1605, 1492, 1462 (Ar), 1175 (CO); δH (400 MHz) 1.17 (3H, t, J7.1, 
OCH2CH3), 1.25 [3H, d, J 6.9, C(4)H3], 2.37 [3H, s, C(2')CH3], 2.52 [1H, dd, A of ABX, JAB 
15.2, JAX 8.5, one of C(2)H2], 2.61 [1H, dd, B of ABX, JAB 15.2, JBX 6.6, one of C(2)H2], 
3.46–3.61 [1H, m, X of ABX, C(3)H], 4.07 (2H, q, J 7.1, OCH2CH3), 7.07-7.19 (4H, m, 
ArH). δC (75.5 MHz) 14.2, 19.5, 21.3 [3 x CH3, C(4)H3, OCH2CH3, C(2’)CH3], 31.5 [CH, 
C(3)H], 42.2 [CH2, C(2)H2], 60.3 [CH2, OCH2CH3], 125.1, 126.1, 126.3, 130.4 (4 x CH, 
aromatic CH), 135.3, 143.9 (2 x C, aromatic C), 172.6 [C, C(1)]. HRMS (ES+): Exact mass 
calculated for C13H18O2 [M+H]
+
 207.1385. Found 207.1393; m/z (ES+) 207.1 
{[(C13H18O2)+H]
+
, 71%}, 202.1 (100%), 161.1 {[(C11H13O)-C2H5O]
-
, 48%}, 151.0 (68%), 
141.0 (24%). 
 
(±)-Ethyl 3-(4-methoxyphenyl)butanoate (±)-3h
53
  
This was prepared following the procedure described for (±)-3b, from 3-(4-
methoxyphenyl)butanoyl chloride (±)-2h (8.49 g, 39.9 mmol), triethylamine (6.7 mL, 47.88 
mmol), dichloromethane (50 mL) and distilled ethanol (5.8 mL, 99.75 mmol) to yield the 
crude ester (±)-3h (6.68 g) as an orange oil. Purification by chromatography on silica gel 
using hexane/ethyl acetate as eluant (gradient elution 0-10% ethyl acetate) gave the ester (±)-
3h (5.32 g, 56%) as a clear oil. vmax/cm
-1
 (film) 2966 (CH), 1732 (CO), 1613, 1513, 1461 
(Ar), 1174 (CO); δH (400 MHz) 1.18 (3H, t, J7.1, OCH2CH3), 1.27 [3H, d, J 7.0, C(4)H3], 2.5 
[1H, dd, A of ABX, JAB 14.9, JAX 8.0, one of C(2)H2], 2.57 [1H, dd, B of ABX, JAB 15.0, JBX 
7.2, one of C(2)H2], 3.17–3.29 [1H, m, X of ABX, C(3)H], 3.77 (3H, s, OCH3), 4.07 (2H, q, J 
7.1, OCH2CH3), 6.81-6.85 [2H, m, C(3’)H, C(5’)H], 7.12-7.16 [2H, m, C(2’)H, C(6’)H]. 
 
Enzyme Screening 
 
General procedure for the hydrolase catalysed kinetic resolution of the 3-aryl alkanoic 
ethyl esters (±)-3a-i (analytical scale). 
 
A spatula tip of enzyme (~5-10 mg) was added to the substrate (±)-3a-i (~50 mg) in 0.1 M 
phosphate buffer, pH 7 (4.5 mL). Co-solvents (17% v/v) were added as indicated in Table 3. 
The reaction vessel was shaken at 700-750 rpm and incubated at the appropriate temperature 
for the required length of time. The aqueous layer was extracted with diethyl ether (3 x 5 mL) 
and the combined organic extracts were filtered through celite and concentrated under 
reduced pressure. The sample was analysed by 
1
H NMR spectroscopy, reconcentrated and 
dissolved in a mixture of hexane:iso-propyl alcohol (HPLC grade) and enantioselectivity 
determined by chiral HPLC. The results of the screen are summarised in the appropriate 
Tables 1-10. 
 
Preparative scale hydrolysis of (±)-ethyl 3-phenylbutanoate (±)-3a  
Pseudomonas fluorescens (108 mg) was added to ethyl 3-phenylbutanoate (±)-3a (510 mg, 
2.65 mmol) in 0.1 M phosphate buffer, pH 7 (20 mL) and this was shaken at 750 rpm for 64 h 
at 30 ºC. The solution was filtered through a pad of celite and the hydrolase washed with 
water (2 × 20 mL) and ethyl acetate (10 × 10 mL).  The layers were separated and the 
aqueous layer was extracted with ethyl acetate (2 × 30 mL) and then acidified with 10% HCl 
solution and extracted with a further (3 × 30 mL) ethyl acetate. The combined organic layers 
were washed with brine (1 × 100 mL) dried, filtered and concentrated under reduced pressure 
to produce a clear oil (395 mg). Conversion estimated at 50%.
34
 Purification by column 
chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl acetate) 
gave ester (R)-3a (178 mg, 35%) as a clear oil     
  
 -27.55 (c 1.1, CHCl3), 99% ee, lit
54
     
  
 
+19.00 (c 1.1, CHCl3), (S)-isomer, 90% ee and acid (S)-1a (147 mg, 34%) as a clear oil     
  
 
+27.90 (c 1.0, EtOH), 98% ee, lit
55
     
   +24.50 (c 1.0, EtOH), 97% ee. 
1
H NMR spectra 
were identical to the racemic materials previously prepared. 
Preparative scale hydrolysis of (±)-ethyl 3-phenylpentanoate (±)-3b  
Candida antarctica lipase B (immob) (410 mg) was added to ethyl 3-phenylpentanoate (±)-
3b (408 mg, 1.98 mmol) in 0.1 M phosphate buffer, pH 7 (20 mL) and dioxane (17% v/v, 4 
mL). The reaction mixture was shaken at 750 rpm for 62 h at 30 ºC, the solution was filtered 
through a pad of celite and the hydrolase washed with water (2 × 20 mL) and heptane (10 x 
10 mL). The layers were separated and the aqueous layer was extracted with heptane (3 x 30 
mL). The combined organic layers were washed with brine (1 × 100 mL), dried, filtered and 
concentrated under reduced pressure to produce the ester (S)-3b (79.2 mg, 19%) as a light 
yellow oil.     
  
 +9.455 (c 0.55, CHCl3), 65% ee, lit
56
     
  
 -18.3 (c 1.1, CHCl3), (R)-isomer, 
97% ee. The aqueous layer was acidified with 10% HCl solution and extracted with (3 × 30 
mL) ethyl acetate. The combined organic layers were washed with brine (1 × 100 mL), dried, 
filtered and concentrated under reduced pressure to produce the acid (R)-1b (77.6 mg, 22%) 
as a yellow oil.     
  
 -33.73 (c 1.37, C6H6), 90% ee, lit
39
     
  
 +42.3 (c 8.0, C6H6), (S)-
isomer, 83% ee. Conversion estimated at 42%.
34
 
1
H NMR spectra were identical to the 
racemic materials previously prepared. 
Preparative scale hydrolysis of (±)-ethyl 4-methyl-3-phenylpentanoate (±)-3c  
This was prepared following the procedure described for (±)-3b from Candida antarctica 
lipase B (immob) (426 mg) and ethyl 4-methyl-3-phenylpentanoate (±)-3c (428 mg, 1.94 
mmol) in 0.1 M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 
rpm for 63 h at 30 ºC to produce the ester (R)-3c (107 mg, 25%) as a clear oil     
  
 +7.05 (c 
1.0, CHCl3), 26% ee, lit
56
     
  
 -25.4 (c 1.0, CHCl3), (S)-isomer, 98% ee, and the acid (S)-1c 
(88 mg, 24%) as a clear oil     
  
 -24.35 (c 0.655, CHCl3), 98% ee, lit
57
     
   +28.12 (c 
1.855, CHCl3), (R)-isomer, 96% ee. Conversion estimated at 21%.
34
 
1
H NMR spectra were 
identical to the racemic materials previously prepared. 
 
Preparative scale hydrolysis of (±)-ethyl 4,4-dimethyl-3-phenylpentanoate (±)-3d  
This was prepared following the procedure described for (±)-3b from Candida antarctica 
lipase B (immob) (200 mg) and ethyl 4,4-dimethyl-3-phenylpentanoate (±)-3d (200 mg, 0.85 
mmol) in 0.1 M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 
rpm for ~65 h at 35 ºC and at 40 ºC for the final 24 h to produce the ester (R)-3d (79 mg, 
39%) as a clear oil.     
  
 +8.00 (c 1.0, CHCl3), 12% ee and the acid (S)-1d (23 mg, 13%) as a 
yellow oil which solidified overnight     
  
 -10.53 (c 0.114, CHCl3), 99% ee, lit
58
     
   -20.4 
(c 2.2, CHCl3), 91% ee. Conversion estimated at 11%.
34
  
1
H NMR spectra were identical to 
the racemic materials previously prepared. 
 
 
Preparative scale hydrolysis of (±)-ethyl 3-(4-methylphenyl)butanoate (±)-3e  
This was prepared following the procedure described for (±)-1a from Pseudomonas cepacia 
P1 (95 mg) and ethyl 3-(4-methylphenyl)butanoate (±)-3e (446 mg, 2.26 mmol) in 0.1 M 
phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 rpm for 62 h at 30 
ºC to produce a yellow oil (361 mg). Conversion estimated at 49%.
34
 Purification by column 
chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl acetate) 
gave ester (R)-3e (145 mg, 31%) as a clear oil     
  
 -28.67 (c 3.5, CHCl3), 97% ee, lit
24
     
   
-26.2 (c 3.5, CHCl3), 92% ee and acid (S)-1e (163 mg, 40%) as a yellow oil which solidified 
overnight     
  
 +31.80 (c 1.0, CHCl3), ≥99% ee, lit
24
     
   +34.2 (c 1.0, CHCl3), 99% ee. 
1
H 
NMR spectra were identical to the racemic materials previously prepared. 
 
Preparative scale hydrolysis of ethyl 3-(3-methylphenyl)butanoate (±)-3f  
This was prepared following the procedure described for (±)-3a from Pseudomonas 
fluorescens (94 mg) and ethyl 3-(3-methylphenyl)butanoate (±)-3f (471 mg, 2.28 mmol) in 
0.1 M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 rpm for 62 h 
at 30 ºC to produce a yellow oil (232 mg). Conversion estimated at 49%.
34
 Purification by 
column chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl 
acetate) gave ester (R)-3f (105 mg, 22%) as a yellow oil     
   -24.40 (c 1.0, CHCl3), 94% ee 
and acid (S)-1f (107 mg, 26%) as a clear oil     
   +32.32 (c 0.622, CHCl3), ≥99% ee. 
1
H 
NMR spectra were identical to the racemic materials previously prepared. 
 
Preparative scale hydrolysis of ethyl 3-(2-methylphenyl)butanoate (±)-3g  
This was prepared following the procedure described for (±)-1a from Pseudomonas 
fluorescens (74 mg) and ethyl 3-(2-methylphenyl)butanoate (±)-3g (371 mg, 1.80 mmol) in 
0.1 M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 rpm for 66 h 
at 30 ºC to produce a yellow oil (268 mg). Conversion estimated at 50%.34 Purification by 
column chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl 
acetate) gave ester (R)-3g (100 mg, 27%) as a clear oil     
   -11.00 (c 1.0, CHCl3), 98% ee 
and acid (S)-1g (90 mg, 28%) as a yellow oil     
   +24.17 (c 1.38, CHCl3), ≥99% ee. 
1
H 
NMR spectra were identical to the racemic materials previously prepared. 
 
Preparative scale hydrolysis of (±)-ethyl 3-(4-methoxyphenyl)butanoate (±)-3h  
This was prepared following the procedure described for (±)-1a from Pseudomonas 
fluorescens (100 mg) and ethyl 3-(4-methoxyphenyl)butanoate (±)-3h (498 mg, 2.24 mmol) 
in 0.1 M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 rpm for 64 
h at 30 ºC to produce an orange oil (428 mg). Conversion estimated at 51%.
34
 Purification by 
column chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl 
acetate) gave ester (R)-3h (212 mg, 43%) as a clear oil     
   -30.03 (c 1.034, CHCl3), 99% 
ee and acid (S)-1h (99 mg, 23%) as a yellow oil     
   +26.25 (c 1.0, EtOH), 97% ee, lit
55
 
    
  
 +27.50 (c 1.0, EtOH) 94% ee. 
1
H NMR spectra were identical to the racemic materials 
previously prepared. 
 
Preparative scale hydrolysis of (±)-ethyl 3-(4-fluorophenyl)butanoate (±)-3i  
This was prepared following the procedure described for (±)-1a from Pseudomonas 
fluorescens (45 mg) and ethyl 3-(4-fluorophenyl)butanoate (±)-3i (221 mg, 1.05 mmol) in 0.1 
M phosphate buffer, pH 7 (20 mL). The reaction mixture was shaken at 750 rpm for 64 h at 
30 ºC to produce a yellow oil (171 mg). Conversion estimated at 51%.
34
 Purification by 
column chromatography using hexane/ethyl acetate as eluant (gradient elution 10-40% ethyl 
acetate) gave ester (R)-3i (71 mg, 32%) as a clear oil     
   -24.34 (c 1.0, CHCl3), ≥99% ee, 
and acid (S)-1i (67 mg, 35%) as a brown oil     
   +30.51 (c 1.016, CHCl3), 97% ee. 
1
H 
NMR spectra were identical to the racemic materials previously prepared. 
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